Trial Profile
A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel group study to assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of oral Rupatadine in Healthy Japanese Subjects after Single and Multiple Ascending Doses
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Rupatadine (Primary)
- Indications Perennial allergic rhinitis; Seasonal allergic rhinitis; Urticaria
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Uriach
- 01 Jan 2018 Results published in the Clinical Pharmacology in Drug Development.
- 08 Mar 2016 New trial record